- Home
- ADPT vs SAFT Comparison
ADPT vs SAFT Comparison
Compare ADPT & SAFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- SAFT
- Stock Information
- Founded
- ADPT 2009
- SAFT 1979
- Country
- ADPT United States
- SAFT United States
- Employees
- ADPT N/A
- SAFT N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- SAFT Property-Casualty Insurers
- Sector
- ADPT Health Care
- SAFT Finance
- Exchange
- ADPT Nasdaq
- SAFT Nasdaq
- Market Cap
- ADPT 1.4B
- SAFT 1.2B
- IPO Year
- ADPT 2019
- SAFT N/A
- Fundamental
- Price
- ADPT $11.48
- SAFT $76.32
- Analyst Decision
- ADPT Strong Buy
- SAFT
- Analyst Count
- ADPT 7
- SAFT 0
- Target Price
- ADPT $10.57
- SAFT N/A
- AVG Volume (30 Days)
- ADPT 2.2M
- SAFT 90.3K
- Earning Date
- ADPT 07-31-2025
- SAFT 08-06-2025
- Dividend Yield
- ADPT N/A
- SAFT 4.69%
- EPS Growth
- ADPT N/A
- SAFT 40.60
- EPS
- ADPT N/A
- SAFT 4.90
- Revenue
- ADPT $189,527,000.00
- SAFT $1,153,213,000.00
- Revenue This Year
- ADPT $24.46
- SAFT N/A
- Revenue Next Year
- ADPT $20.25
- SAFT N/A
- P/E Ratio
- ADPT N/A
- SAFT $16.13
- Revenue Growth
- ADPT 8.61
- SAFT 17.03
- 52 Week Low
- ADPT $3.30
- SAFT $70.71
- 52 Week High
- ADPT $12.43
- SAFT $90.00
- Technical
- Relative Strength Index (RSI)
- ADPT 63.39
- SAFT 37.21
- Support Level
- ADPT $11.17
- SAFT $76.91
- Resistance Level
- ADPT $12.43
- SAFT $80.15
- Average True Range (ATR)
- ADPT 0.59
- SAFT 1.72
- MACD
- ADPT 0.03
- SAFT -0.15
- Stochastic Oscillator
- ADPT 62.45
- SAFT 4.79
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About SAFT Safety Insurance Group Inc.
Safety Insurance Group Inc is a provider of private passenger automobile, commercial automobile, and homeowners insurance in Massachusetts. The company also offers property and casualty insurance products, including commercial automobiles, homeowners, dwelling fire, umbrella, and business owner policies. It operates in the business segment of Property and casualty insurance operations.